152 related articles for article (PubMed ID: 7881646)
1. Eosinophil viability-enhancing activity in sputum from patients with bronchial asthma, Contributions of interleukin-5 and granulocyte/macrophage colony-stimulating factor.
Adachi T; Motojima S; Hirata A; Fukuda T; Makino S
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 1):618-23. PubMed ID: 7881646
[TBL] [Abstract][Full Text] [Related]
2. Cytokine concentrations in sputum from patients with cystic fibrosis and their relation to eosinophil activity.
Koller DY; Nething I; Otto J; Urbanek R; Eichler I
Am J Respir Crit Care Med; 1997 Mar; 155(3):1050-4. PubMed ID: 9116985
[TBL] [Abstract][Full Text] [Related]
3. Detection of transforming growth factor-beta in sputum from patients with bronchial asthma by eosinophil survival assay and enzyme-linked immunosorbent assay.
Adachi T; Motojima S; Hirata A; Fukuda T; Kihara N; Makino S
Clin Exp Allergy; 1996 May; 26(5):557-62. PubMed ID: 8735868
[TBL] [Abstract][Full Text] [Related]
4. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction.
Ohnishi T; Kita H; Weiler D; Sur S; Sedgwick JB; Calhoun WJ; Busse WW; Abrams JS; Gleich GJ
Am Rev Respir Dis; 1993 Apr; 147(4):901-7. PubMed ID: 8466126
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte-macrophage colony-stimulating factor, eosinophils and eosinophil cationic protein in subjects with and without mild, stable, atopic asthma.
Woolley KL; Adelroth E; Woolley MJ; Ellis R; Jordana M; O'Byrne PM
Eur Respir J; 1994 Sep; 7(9):1576-84. PubMed ID: 7995384
[TBL] [Abstract][Full Text] [Related]
6. Late response to allergen is associated with increased concentrations of tumor necrosis factor-alpha and IL-5 in induced sputum.
Keatings VM; O'Connor BJ; Wright LG; Huston DP; Corrigan CJ; Barnes PJ
J Allergy Clin Immunol; 1997 May; 99(5):693-8. PubMed ID: 9155837
[TBL] [Abstract][Full Text] [Related]
7. [Eosinophil activation in acute asthma attacks evaluated by electronmicroscopic findings of eosinophils and the concentration of eosinophil cationic protein in sputum].
Oohashi Y; Motojima S; Kushima A; Tateishi K; Fukuda T; Makino S
Arerugi; 1991 Oct; 40(10):1265-71. PubMed ID: 1772349
[TBL] [Abstract][Full Text] [Related]
8. Effects of allergen challenge on eosinophils, eosinophil cationic protein, and granulocyte-macrophage colony-stimulating factor in mild asthma.
Woolley KL; Adelroth E; Woolley MJ; Ellis R; Jordana M; O'Byrne PM
Am J Respir Crit Care Med; 1995 Jun; 151(6):1915-24. PubMed ID: 7767540
[TBL] [Abstract][Full Text] [Related]
9. Correlation between airway hyperresponsiveness and airway inflammation in a young adult population: eosinophil, ECP, and cytokine levels in induced sputum.
Obase Y; Shimoda T; Mitsuta K; Matsuo N; Matsuse H; Kohno S
Ann Allergy Asthma Immunol; 2001 Mar; 86(3):304-10. PubMed ID: 11289329
[TBL] [Abstract][Full Text] [Related]
10. IL-5, IL-8 and GM-CSF immunostaining of sputum cells in bronchial asthma and chronic bronchitis.
Hoshi H; Ohno I; Honma M; Tanno Y; Yamauchi K; Tamura G; Shirato K
Clin Exp Allergy; 1995 Aug; 25(8):720-8. PubMed ID: 7584683
[TBL] [Abstract][Full Text] [Related]
11. [The relationship of eosinophil viability enhancing activity in sputum and clinical symptoms in asthma].
Atsuta J; Fujisawa T; Iguchi K
Arerugi; 1996 Oct; 45(10):1082-8. PubMed ID: 8958654
[TBL] [Abstract][Full Text] [Related]
12. Profiles of proinflammatory cytokines in sputum from different groups of severe asthmatic patients.
Dente FL; Carnevali S; Bartoli ML; Cianchetti S; Bacci E; Di Franco A; Vagaggini B; Paggiaro P
Ann Allergy Asthma Immunol; 2006 Sep; 97(3):312-20. PubMed ID: 17042136
[TBL] [Abstract][Full Text] [Related]
13. Eosinophil activation markers in induced sputum in asthmatics.
Jang AS; Choi IS
Korean J Intern Med; 2000 Jan; 15(1):1-7. PubMed ID: 10714084
[TBL] [Abstract][Full Text] [Related]
14. [Sensitivity of sputum eosinophil cationic protein level for monitoring asthmatic patients with normal peak expiratory flow].
Nakazawa T; Kagami M; Matumura R; Kawashima T; Matuzuwa Y; Takada M
Arerugi; 1999 Oct; 48(10):1153-60. PubMed ID: 10554401
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of measuring levels of sputum and serum ECP and serum IL-5 in bronchial asthma.
Motojima S; Akutsu I; Fukuda T; Makino S; Takatsu K
Allergy; 1993; 48(17 Suppl):98-106; discussion 110-1. PubMed ID: 8109721
[No Abstract] [Full Text] [Related]
16. [Creola bodies and the eosinophil cationic protein in sputum in acute asthmatic attacks with respect to their clinical significance].
Ogata H; Motojima S; Fukuda T; Makino S
Arerugi; 1990 Dec; 39(12):1567-75. PubMed ID: 2096802
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte macrophage colony-stimulating factor is the main cytokine enhancing survival of eosinophils in asthmatic airways.
Park CS; Choi YS; Ki SY; Moon SH; Jeong SW; Uh ST; Kim YH
Eur Respir J; 1998 Oct; 12(4):872-8. PubMed ID: 9817161
[TBL] [Abstract][Full Text] [Related]
18. Macrophage migration inhibitory factor (MIF) in bronchial asthma.
Yamaguchi E; Nishihira J; Shimizu T; Takahashi T; Kitashiro N; Hizawa N; Kamishima K; Kawakami Y
Clin Exp Allergy; 2000 Sep; 30(9):1244-9. PubMed ID: 10971470
[TBL] [Abstract][Full Text] [Related]
19. Eosinophil cationic protein levels in induced sputum correlate with the severity of bronchial asthma.
Fujimoto K; Kubo K; Matsuzawa Y; Sekiguchi M
Chest; 1997 Nov; 112(5):1241-7. PubMed ID: 9367463
[TBL] [Abstract][Full Text] [Related]
20. Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro.
Tai PC; Sun L; Spry CJ
Clin Exp Immunol; 1991 Aug; 85(2):312-6. PubMed ID: 1864012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
